ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY4 | Adenylate cyclase 4 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY6 | Adenylate cyclase 6 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ADCY9 | Adenylate cyclase 9 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins
| | | | | Expressed in all |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADIG | Adipogenin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIPOR1 | Adiponectin receptor 1 | Predicted membrane proteins
| | | | | Expressed in all |
ADIPOR2 | Adiponectin receptor 2 | Predicted membrane proteins
| | | | | Expressed in all |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADPGK | ADP-dependent glucokinase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADPRM | ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB2 | Adrenoceptor beta 2, surface | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
ADRBK2 | Adrenergic, beta, receptor kinase 2 | Enzymes
| | | | | Mixed |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGAP10 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 10 | | | | | | Expressed in all |
AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | | | | | | Tissue enhanced |
AGAP9 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 | | | | | | Expressed in all |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
AGER | Advanced glycosylation end product-specific receptor | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | Enzymes Predicted membrane proteins
| | | | | Mixed |
AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT6 | 1-acylglycerol-3-phosphate O-acyltransferase 6 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGR2 | Anterior gradient 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AGT | Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AGTR2 | Angiotensin II receptor, type 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AHCTF1 | AT hook containing transcription factor 1 | | | | | | Expressed in all |
AHR | Aryl hydrocarbon receptor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
AIFM2 | Apoptosis-inducing factor, mitochondrion-associated, 2 | Mitochondrial proteins
| | | | | Expressed in all |
AIG1 | Androgen-induced 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AIRE | Autoimmune regulator | Disease related genes Transcription factors
| | | | | Tissue enhanced |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP8L | A kinase (PRKA) anchor protein 8-like | | | | | | Expressed in all |